GO:0071025 RNA surveillance: Genes, Functions & Methods

RNA surveillance, defined by the Gene Ontology term GO:0071025, is a biological process that identifies and degrades defective or aberrant RNAs. This process is critical for maintaining the fidelity of gene expression, as it prevents the accumulation of faulty transcripts that could otherwise be translated into truncated or toxic proteins. The term encompasses several quality control pathways, including nonsense-mediated decay (NMD), non-stop decay (NSD), and no-go decay (NGD), which collectively ensure that only properly processed mRNAs are available for translation. Researchers study RNA surveillance to understand how cells cope with errors in transcription, splicing, and translation, and how defects in these pathways contribute to human disease. The importance of RNA surveillance extends beyond basic RNA biology; it is implicated in viral defense, cancer progression, and neurodegenerative disorders. Given its central role in cellular homeostasis, RNA surveillance is a focal point for therapeutic intervention and biomarker discovery.

RNA surveillance (GO:0071025) is the cellular process that detects and eliminates defective or aberrant RNA molecules. It includes mechanisms that recognize premature stop codons, stalled ribosomes, and other RNA abnormalities, leading to their degradation. This quality control system prevents the production of harmful proteins and maintains transcriptome integrity.

RNA surveillance is vital because it safeguards the transcriptome and proteome from errors that arise during gene expression. Without efficient surveillance, aberrant RNAs can be translated into truncated proteins that aggregate or interfere with normal cellular functions, leading to diseases such as cancer and neurodegeneration. Moreover, RNA surveillance pathways are emerging as key modulators of immune responses and viral infections, making them attractive targets for therapeutic development.

The following genes encode core components of the RNA surveillance machinery, each with distinct roles and research relevance.

RNA surveillance is regulated at multiple levels. The NMD pathway is modulated by phosphorylation of UPF1 by SMG1, which is antagonized by phosphatases. Additionally, the integrated stress response (ISR) can inhibit translation and affect NMD efficiency. Other regulators include the mTOR pathway, which influences general mRNA turnover, and microRNAs that target surveillance factors. Viral proteins can also interfere with RNA surveillance to evade host defenses.

Dysregulation of RNA surveillance is increasingly recognized in cancer. For example, mutations in UPF1 and SMG1 have been found in various tumors, leading to impaired NMD and accumulation of aberrant transcripts that promote oncogenesis. Targeting RNA surveillance pathways is being explored as a therapeutic strategy.

Defects in RNA surveillance contribute to neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. Mutations in genes like UPF1 and SMG6 have been linked to ALS, and impaired NMD leads to toxic protein aggregation.

Mutations in RNA surveillance genes cause inherited diseases. For instance, UPF3B mutations result in X-linked intellectual disability, and EXOSC3 mutations cause pontocerebellar hypoplasia. These disorders highlight the importance of RNA quality control in development.

RNA-seq is used to quantify changes in transcript levels upon RNA surveillance perturbation. It can identify aberrant transcripts that accumulate when NMD is inhibited, providing insights into pathway targets.

Ribo-seq measures ribosome occupancy on mRNAs, revealing translation efficiency and ribosome stalling. It is particularly useful for studying NGD and NSD.

Mass spectrometry-based proteomics can identify protein interactions and post-translational modifications of RNA surveillance factors, such as UPF1 phosphorylation.

Fluorescence microscopy with tagged surveillance proteins (e.g., GFP-UPF1) allows visualization of their subcellular localization and dynamics in live cells.

Researchers studying RNA surveillance-related genes often need to determine whether a candidate gene is causally involved in RNA quality control and how its dysfunction contributes to disease. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.

RNA surveillance (GO:0071025) is a fundamental biological process that safeguards gene expression by degrading aberrant RNAs. Its dysregulation is implicated in a wide range of human diseases, making it a compelling area of research. Advances in CRISPR technology and high-throughput methods are accelerating our understanding of RNA surveillance mechanisms and their therapeutic potential. EDITGENE is committed to providing researchers with the tools and services needed to explore this critical pathway.